畜牧兽医学报 ›› 2014, Vol. 45 ›› Issue (1): 94-100.doi: 10.11843/j.issn.0366-6964.2014.01.013

• 预防兽医 • 上一篇    下一篇

牛病毒性腹泻-黏膜病病毒E2基因在卡介苗中的优化表达

曾范利1,张云2,张梦3,时坤1,李建明1,刘菲2,李晶2,杜锐4*   

  1. (1.吉林农业大学中药材学院,长春 130118;2.吉林农业大学动物科学技术学院,长春 130118;3.长春金赛药业有限责任公司,长春 130012;4.吉林农业大学研究生学院,教育部动物生产及产品质量安全重点实验室,吉林省药用动物二级实验室,长春 130118)
  • 收稿日期:2013-07-26 出版日期:2014-01-23 发布日期:2014-01-23
  • 通讯作者: 杜锐,E-mail:durui71@126.com
  • 作者简介:曾范利(1980-),女,蒙古族,吉林松原人,讲师,博士,主要从事经济动物疫病研究,E-mail:fanli6668@126.com
  • 基金资助:

    国家科技支撑计划(2011BAI03B02-1);国家自然科学基金(3107214031272565);吉林省科技厅科技支撑计划(20120225);吉林农业大学博士启动基金(201209

Cloning and Optimizing Expression of E2 Gene of Bovine Viral Diarrhea-mucosal Disease Virus in BCG

ZENG Fan-li1, ZHANG Yun2, ZHANG Meng3, SHI Kun1, LI Jian-ming1, LIU Fei2, LI Jing2, DU Rui4*   

  1. (1.College of Chinese Medicine Materials, Jilin Agricultural University, Changchun 130118, China;2.College of Animal Science &Technology, Jilin Agricultural University, Changchun 130118, China;3.Changchun Kinsey Pharmaceutical Co.Ltd, Changchun 130012, China;4.Key Laboratory of Animal Production,Product Quality and Security of Ministry of Education of the people′s Republic of China, Level 2 Laboratory of Medical Animal of Jilin Province, College of Graduate, Jilin Agricultural University, Changchun 130118, China)
  • Received:2013-07-26 Online:2014-01-23 Published:2014-01-23

摘要:

为构建牛病毒性腹泻-黏膜病病毒(BVDV)基因工程活载体疫苗,根据已知的BVDV Changchun184毒株E2基因序列,利用DNAStar生物学软件对其进行分析,预测了可能存在的抗原表位,设计6对引物,分别扩增了包含预测抗原位点的6个片段,1297 aa1345 aa1374 aa45297 aa45345 aa45374 aa,克隆至穿梭表达载体pMV361中,经酶切、PCR扩增和测序证实已正确插入到表达载体中,构建了6个原核表达质粒。阳性重组质粒通过电转化到卡介苗(BCG)感受态中,热诱导后,进行SDS-PAGE分析和免疫印迹检测。结果表明6个重组质粒在卡介苗中均有不同程度的表达,表达产物与理论推测的相对分子质量一致。Western blot结果显示其融合蛋白能被牛抗BVDV的阳性血清识别,具有相应的反应原性。本研究为进一步研究BVDV基因工程活载体疫苗奠定了基础。

Abstract:

To develop genetic engineering living-vector vaccine of Bovine viral diarrhea-mucosal disease virus (BVDV) E2 gene of BVDV Changchun184 strain was selected and the complete sequence was analyzedthen the epitopes of E2 protein were predicted by bioinformatics software.Six pairs of primers were designed according to E2 gene sequenceand the epitopes coding regions (1-2971-3451-37445-29745-34545-374) of E2 gene were amplified by PCR and cloned into pMV361 vector.PCRrestriction endonuclease digestion and sequence analysis proved that the 6 fragments were inserted into the expected position.It was indicated that the six prokaryotic expression plasmids were constructed.The positive recombinant plasmids were electro-transformed into BCG for expression at 45 .The SDS-PAGE and Western blot results indicated that the recombinant proteins could react with polyclonal antibody against BVDV.Our study provides a basis for the further studies on genetic engineering living-vector vaccine of BVDV.

中图分类号: